FMTX Stock
Price Chart
FMTX Financial and Trading Overview
| stock price | |
| Previous Close | 20.01 |
| Open | 20 |
| Bid | 0 x 28000 |
| Ask | 0 x 21500 |
| Day's Range | 19.98 - 20.01 |
| 52 Week Range | 4.95 - 20.28 |
| Volume | 0 |
| Avg. Volume | 1.55M |
| Market Cap | 1.01B |
| Beta (5Y Monthly) | -0.947609 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21 |
FMTX Valuation Measures
| Enterprise Value | 594.09M |
| Trailing P/E | N/A |
| Forward P/E | -5.5583334 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 2.3090236 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -3.151 |
Trading Information
Stock Price History
| Beta (5Y Monthly) | -0.947609 |
| 52-Week Change | 5.70% |
| S&P500 52-Week Change | -15.68% |
| 52 Week High | 20.28 |
| 52 Week Low | 4.95 |
| 50-Day Moving Average | 17.92 |
| 200-Day Moving Average | 10.9 |
FMTX Share Statistics
| Avg. Volume (3 month) | 1.55M |
| Avg. Daily Volume (10-Days) | 200.69K |
| Shares Outstanding | 47.86M |
| Float | 33.11M |
| Short Ratio | 0.4 |
| % Held by Insiders | 5.13% |
| % Held by Institutions | 91.07% |
| Shares Short | 1.27M |
| Short % of Float | 3.30% |
| Short % of Shares Outstanding | 2.66% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | June 30, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -21.94% |
| Return on Equity (ttm) | -38.26% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | -125661000 |
| EBITDA | -188563008 |
| Net Income Avi to Common (ttm) | -190155008 |
| Diluted EPS (ttm) | -3.821 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 395.9M |
| Total Cash Per Share (mrq) | 8.27 |
| Total Debt (mrq) | 32.55M |
| Total Debt/Equity (mrq) | 7.85 |
| Current Ratio (mrq) | 12.743 |
| Book Value Per Share (mrq) | 8.666 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -170070000 |
| Levered Free Cash Flow (ttm) | -106877128 |
Profile of
| Country | |
| State | MA |
| City | Watertown |
| Address | 300 North Beacon Street |
| ZIP | 02472 |
| Phone | 617 679 1970 |
| Website | https://www.formatherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 189 |
Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobinopathies; and FT-7051 for the treatment of metastatic castration-resistant prostate cancer. The company is also developing Olutasidenib, a selective inhibitor for cancers with isocitrate dehydrogenase 1 gene mutations, which is in Phase II trial for the treatment of relapsed/refractory acute myeloid leukemia and Phase I trial to treat glioma; and FT-8225, a liver-targeted fatty-acid synthase inhibitor designed to block de novo lipogenesis in the liver. Forma Therapeutics Holdings, Inc. was founded in 2007 and is headquartered in Watertown, Massachusetts. As of October 14, 2022, Forma Therapeutics Holdings, Inc. operates as a subsidiary of Novo Nordisk A/S.
Q&A For Stock
What is a current FMTX stock price?
FMTX stock price today per share is .
How to purchase stock?
You can buy FMTX shares on the exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for ?
The stock symbol or ticker of is FMTX.
Which industry does the company belong to?
The industry is Biotechnology.
How many shares does have in circulation?
The max supply of shares is 0.
What is Price to Earnings Ratio (PE Ratio)?
PE Ratio is 0.00000000 now.
What was earnings per share over the trailing 12 months (TTM)?
EPS is 0 over the trailing 12 months.
Which sector does the company belong to?
The sector is Healthcare.
FMTX included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}